Richard Pollok

[Richard Pollok @SGH_IBD]

I think you’re right Jon
I think the issue is with previous melanoma or melanoma in remission where IFX and maybe other drugs may impair immune surveillance. Melanoma may represent years later

[Jonathan Segal @Jonathansegal85]

@JHashashMD @MondayNightIBD @DCharabaty @DrJordanAxelrad @abbvie @JNJInnovMed @TakedaPharma @DavidFaleckMD @fudmanMD @FunchainMD @ibdtweets @IBD_JohnD @EugeneYenMD @JeanFredericCo1 @IBDimmunology @DrsMeena @clivejmiranda @datadriven_tdoc @IBD_FloMD @MLongMD @DavidHudesmanMD @shannonchangmd @SimonHongMD @HolmerMd @DrMikeDolinger @ryanungaro @AdamFayeMD @EdwardLoftus2 @EdBarnesMD @BenClickMD @tommasoparigi @AndresYarur @ownyourcrohns @JustinFieldMD @MeganMurphyGI @AmyStewartNP @LindsayClarkeMD @KDeFelice_IBD @AimenKhanMD @EdithHoMD @IBD_DrEMF @IBDPharmD @ElisaBodenIBDMD @SalamBachour @RahulSDalalMD @md_ayanna @ibddoctor @DrPhil_Gu @IBDMD @MRegueiroMD We use a huge amount of anti-tnf for immune checkpoint inhibitor colitis- mostly for those with metastatic melanoma. I’m not convinced there is any significant risk of making melanoma worse or therapies less effective. I am more relaxed in this setting

[Ramon Bataller @rabataller]

How do I write scientific papers, reviews, grants, and abstracts?

Sharing 30 years of experience in one practical table. ⬇️

[Chris Lamb @ProfChrisLamb]

📢 New paper out!

✨ Research‑active hospitals deliver better patient‑reported IBD care ✨

Thanks to @BMJOpen_Gastro for publishing our paper of national data linking research‑active IBD services with higher patient‑reported quality of care.

https://t.co/hDMv6tOAV2

🧵 1/6

[Jean-Frederic Colombel @JeanFredericCo1]

Prediction and Prevention of Inflammatory Bowel Disease: A Call to Act... https://t.co/ixJgDRdlZj

[Richard Pollok @SGH_IBD]

What interests me is there are no trials of steroid tapering regimes in IBD as far as I am aware

[Shomron Ben-Horin @ShomronH]

3-day pulse high-dose IV steroids followed by standard steroids in moderate+ UC has similar mid and long term outcomes as standard prednisone in bio-naive pts. Kudo to #GETECCU for addressing a very pragmatic daily scenario. A study that had to be done !.

[Shomron Ben-Horin @ShomronH]

3-day pulse high-dose IV steroids followed by standard steroids in moderate+ UC has similar mid and long term outcomes as standard prednisone in bio-naive pts. Kudo to #GETECCU for addressing a very pragmatic daily scenario. A study that had to be done !.

[Nature Reviews Gastroenterology & Hepatology @NatRevGastroHep]

New online! Mechanisms of chronic abdominal pain in inflammatory bowel disease and implications for treatment https://t.co/xaDJlkFoim

[DrShahidaDin @ShahidaDin1]

Went to the 1st IBD focused endoscopy training day ever in >20 years of IBD practice! Hosted by St George’s Hospital @Sash_Honap @Kesavan_Kandiah @VCsurgery @SGH_IBD Prototype for refinement & wider dissemination @BritSocGastro @JAG_Endoscopy 🙌🏽🤗

[Anjan Dhar @anjan_dhar6]

Congratulations to two well known researchers in the field of luminal gastroenterology for being awarded the UEG Rising Star Awards 2026. Best wishes from the BSG community for your well deserved honour. @BritSocGastro

[Richard Pollok @SGH_IBD]

@drkeithsiau @docxusofficial Is this a real person who replied Keith

[ignacio catalan @ign76]

Finally out! 💫

[Beatriz Gros @Bealoquebea]

It was such a priviledge to work with Triana Lobaton @DrGVarkas @ReinhartSpeecka in this review where we go through the evidence in combining advanced therapies in IBD+EIM/IMIDs

🌟Who, what, when and at what cost?

https://t.co/RTf4Kdn99t

@FrontGastro_BMJ

[Richard Pollok @SGH_IBD]

@drkeithsiau Why?

[DrShahidaDin @ShahidaDin1]

❤️working with IBD GIRFT handbook team 👌🏽 leadership Dr Bev Oates - practical checklists to implement guidelines and standards to improve 🇬🇧IBD care 🙌🏽- @NHSGIRFT @BritSocGastro @CrohnsColitisUK @ACPGBI @ibdnurse @OrestisArg @ProfChrisLamb @MissLHancock https://t.co/ESLoAJ8OG7

[Samuel Hume @DrSamuelBHume]

Novartis' new malaria treatment cured 97.4% of patients – more than the current best treatment

It kills resistant parasites, too, and probably blocks transmission better than current drugs

Approval is expected next year!

[Richard Pollok @SGH_IBD]

Can we catch up with inaugural online Charlie?

[Charlie Lees @charlie_lees]

@JonnyBlackwell Thanks Jonny - really appreciate you and the team being there

[Richard Pollok @SGH_IBD]

What a great letter constructive and well thought out 👏

[DrShahidaDin @ShahidaDin1]

Link to letter @Gut_BMJ for a deeper dive & summary of de-escalation opportunities, risks and unknowns @JonnyBlackwell @AaronBancil @TakuKobayashiM1 @PlevrisN https://t.co/KOlHiYLG2V

[DrShahidaDin @ShahidaDin1]

Link to letter @Gut_BMJ for a deeper dive & summary of de-escalation opportunities, risks and unknowns @JonnyBlackwell @AaronBancil @TakuKobayashiM1 @PlevrisN https://t.co/KOlHiYLG2V

[DrShahidaDin @ShahidaDin1]

BSG IBD Guideline - De-escalation of Therapy. 🎧⁦@JonnyBlackwell⁩, # FionaRees and me discussing de-escalation strategies in IBD from ⁦@BritSocGastro⁩ ⁦@Gut_BMJ⁩ ⁦@GordonMoranIBD⁩ ⁦@drmorrisgordon⁩
https://t.co/klixh9iey3 https://t.co/2cQxYq98H4

[BSG @BritSocGastro]

👏 Congratulations to Professor Alan Lobo, Consultant Gastroenterologist at Sheffield Teaching Hospitals and longstanding BSG member, who has been shortlisted for Clinical Leader of the Year at the 2025 Health Service Journal (HSJ) Awards!

Read more: https://t.co/f3PYIhVlKm